Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world... Show more
International Business Machines Corporation has had a turbulent 2026. After reaching a record closing high of $329.23 in early June, the stock fell sharply in July when the company pre-announced disappointing second-quarter results, and it has since consolidated well below that peak. As of mid-September, shares were trading near $229, down roughly 22% year to date and about 30% below their record close.
The past 30 days have been comparatively stable, with the stock moving only slightly lower over the period despite notable intraday swings. Sentiment remains cautious as investors weigh the durability of IBM's software franchise against a cyclical slowdown in its mainframe business. The shares carry a forward price-to-earnings multiple in the high teens to low twenties, with a dividend yield approaching 3% supported by one of the longest payout records in technology.
IBM is a global technology and consulting company organized around hybrid cloud, data and artificial intelligence, automation, security, and infrastructure. Its Software segment, which includes Red Hat, watsonx, and recently acquired platforms such as HashiCorp and Confluent, is the largest and most closely watched driver of growth. Roughly 80% of annual software revenue is recurring, providing a relatively stable base of subscription and usage-based income.
The company also operates a Consulting business focused on digital transformation and AI implementation, and an Infrastructure segment centered on the IBM Z mainframe, distributed systems, and storage. IBM Z processes a substantial share of the world's transaction value, underscoring the strategic role of its systems in mission-critical workloads. Investors follow the stock for its hybrid-cloud and AI strategy, its recurring-revenue mix, its disciplined free-cash-flow generation, and its long-running dividend-growth streak, which reached 31 consecutive annual increases in April.
The defining event of recent months was the second-quarter earnings report. Revenue rose only 1% year over year to about $17.2 billion, and adjusted earnings per share of $2.93 came in below the consensus of roughly $2.97 to $3.01. Management attributed the shortfall to customers shifting spending toward servers, storage, and memory ahead of anticipated price increases, which delayed the closing of several large software deals. Full-year constant-currency revenue growth guidance was reduced to a range of 4% to 5%, from a prior outlook of more than 5%.
Within the results, performance was mixed. Software revenue increased 5%, with Red Hat up 11% and OpenShift annualized recurring revenue reaching $2.2 billion, while the Data business grew 19%. However, transaction-processing revenue declined and Infrastructure fell 7%, including a 42% drop in IBM Z mainframe revenue as the z17 launch cycle wound down. Consulting was flat, though signings rose 6%.
On the strategic front, IBM has continued to emphasize quantum computing. Its subsidiary Anderon finalized a $1 billion award under the U.S. CHIPS and Science Act, matched by an additional $1 billion from IBM, to advance a quantum wafer foundry in Albany, New York. The company's roadmap targets Starling, a large-scale fault-tolerant quantum computer, for 2029. Analysts have responded cautiously to the near-term slowdown: HSBC downgraded the stock from Hold to Reduce in July and lowered its price target, while broader consensus ratings reflect a Hold posture.
For investors seeking a more systematic approach, Tickeron's Trending AI Robots page highlights a curated selection of the platform's top-performing and most relevant automated trading strategies. Tickeron offers hundreds of AI trading bots that monitor thousands of tickers, but only those demonstrating notable performance and current relevance appear in this featured section. The bots vary considerably in strategy, timeframe, and performance metrics, allowing users to compare different approaches rather than relying on a single system. Exploring this section can help traders evaluate how data-driven models are positioning across the market and identify strategies aligned with their own objectives.
Looking ahead, the key question is whether IBM's software business can reaccelerate after the second-quarter reset. Investors will focus on recurring revenue trends, Red Hat and OpenShift growth, and the contribution of HashiCorp and Confluent as integrations mature. The company's next earnings report, expected in late October, will be pivotal in confirming whether delayed deals have converted as management indicated.
Other factors to monitor include the pace of the mainframe cycle, the trajectory of free cash flow and the dividend, and the progress of the quantum roadmap. Macroeconomic conditions, enterprise technology spending, and competitive dynamics with peers such as MSFT and ORCL in cloud, data, and AI remain important influences on sentiment. While cash-flow discipline and the recurring-revenue base provide support, sustained share-price recovery will likely depend on evidence that software growth has returned to a firmer footing.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IBM advanced for three days, in 248 of 377 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
IBM moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IBM crossed bullishly above the 50-day moving average on September 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
The Aroon Indicator entered an Uptrend today. In 162 of 263 cases where IBM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IBM as a result. In 48 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
The Moving Average Convergence Divergence Histogram (MACD) for IBM turned negative on September 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 26 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
IBM broke above its upper Bollinger Band on September 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.277) is normal, around the industry mean (7.717). P/E Ratio (20.386) is within average values for comparable stocks, (69.115). Projected Growth (PEG Ratio) (2.171) is also within normal values, averaging (2.305). IBM has a moderately high Dividend Yield (0.029) as compared to the industry average of (0.010). P/S Ratio (3.271) is also within normal values, averaging (145.217).
The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 47 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. IBM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of various computer products through the use of advanced information technology
Industry InformationTechnologyServices